A method for preparing an antibacterial nanofiltration membrane using amikacin as a water phase monomer
By using amikacin as an aqueous monomer and combining it with interfacial polymerization to prepare antibacterial nanofiltration membranes, the problem of nanofiltration membranes being susceptible to microbial contamination was solved, and nanofiltration membranes with high flux and low monovalent salt rejection rate were achieved, simplifying the preparation process and reducing costs.
Patent Information
- Application Number
- CN202610759153.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-29
- Publication Date
- 2026-07-24
AI Technical Summary
Nanofiltration membranes are susceptible to microbial contamination during the separation process, leading to performance degradation. Existing antibacterial nanofiltration membrane preparation processes are complex and costly.
Amikacin was used as the aqueous monomer, combined with sodium dodecyl sulfate and triethylamine, to prepare an antibacterial nanofiltration membrane via interfacial polymerization, forming a polyamide separation layer and improving the membrane's antibacterial properties.
The prepared nanofiltration membrane has high flux, low monovalent salt rejection rate and excellent antibacterial properties, which simplifies the preparation process and reduces raw material costs.
Smart Images

Figure CN122441288A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of composite nanofiltration membrane preparation technology, and particularly relates to a method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer. Background Technology
[0002] Membrane separation technology, as an economical, efficient, and energy-saving water purification method, has attracted widespread attention due to its simple operation process, high separation efficiency, and wide applicability in drinking water production, urban and industrial wastewater treatment, resource recovery, and material separation and concentration. Nanofiltration membranes, with a molecular weight cutoff between 200 and 2000 Da, fall between RO and ultrafiltration membranes. Their unique ion selectivity and high flux endow them with advantages such as low operating pressure and high water purification efficiency.
[0003] During the separation process, nanofiltration membranes are prone to adsorption, deposition, and blockage of various pollutants (such as organic matter, inorganic salts, colloidal particles, and microorganisms) due to the characteristics of their surface and pore structure, leading to a significant decline in membrane performance. Microbial contamination is a particularly prominent issue—the membrane material itself lacks antibacterial properties, failing to effectively inhibit the attachment, reproduction, and biofilm formation of microorganisms on the membrane surface. Once this contamination occurs, it causes a continuous decline in water flux, a decrease in retention rate, and an increase in transmembrane pressure. Simultaneously, biofilm metabolites accelerate the aging and degradation of the membrane material. To restore membrane performance, frequent chemical or physical cleaning is necessary. This not only increases operating energy consumption and reagent costs, but repeated cleaning processes also cause irreversible mechanical damage and chemical corrosion to the membrane material, significantly shortening its lifespan. In practical engineering applications, microbial contamination has become a key bottleneck restricting the stable operation and widespread application of nanofiltration technology, especially in fields with high hygiene requirements such as water treatment, food processing, and biomedicine. The lack of antibacterial properties in membrane materials directly affects the long-term economic efficiency and reliability of the system.
[0004] Therefore, developing nanofiltration membranes with antibacterial properties is essential. Currently, intermediate layer construction is widely used in the development of antibacterial nanofiltration membranes. Jin et al. (J.-M. Jin, H. Ye, T.-H. Li, M.-B. Wu, L. Liu, J.Yao, Antibacterial polyamide nanofiltration membranes with intermediate layers of quaternized cellulose nanocrystal for Mg 2+ / Li +(Separation, Desalination, 582 (2024) 117605.) This study prepared an electric double-layer nanofiltration membrane by introducing positively charged quaternized cellulose nanocrystals (Q-CNCs) beneath a negatively charged polyamide surface. On the one hand, the strong interaction between Q-CNCs and piperazine (PIPs) can regulate the thickness, roughness, and residual groups of the polyamide (PA) layer, thereby improving water flux. On the other hand, the large amount of positive charge carried by Q-CNCs can enhance the retention performance of the negatively charged polyamide surface for divalent cations through long-range Donnan and electrostatic effects. The nanofiltration membrane with a Q-CNC interlayer (QNFM) also exhibits excellent antibacterial properties and has significant application potential in the field of lithium extraction from salt lakes. The construction of the interlayer can significantly improve the antibacterial properties of the nanofiltration membrane, but it increases the complexity of the preparation process.
[0005] Introducing novel antibacterial monomers into nanofiltration membranes is expected to improve their antibacterial properties. Pu et al. (L. Pu, Y. Chen, Y. Zuo, E. Du, X. Xu, G. Rui, M. Peng, G. Sun, High-flux loose nanofiltration membrane based on ammonium monomer for efficient dye / salt separation, Separation and Purification Technology, 382 (2026) 135853.) synthesized an antibacterial macromolecule—aminopyridine quaternary ammonium derivative (APD)—and used it as an aqueous monomer to blend with piperazine to prepare polyamide LNF membranes. The introduction of APD made the membrane surface smoother, more hydrophilic, and negatively charged. The optimized APD-PA membrane had a pure water permeability of 106.1 L / (m³). 2 The membrane exhibits both high dye rejection (99%) and ultra-low salt rejection (5%), achieving efficient separation of dye / salt mixtures. Furthermore, it demonstrates good stability, high antifouling and antibacterial properties, proving the broad application prospects of LNF membranes in treating practical dyeing and printing wastewater. However, the novel monomers used in these studies were designed and synthesized by the researchers themselves, and their preparation process is complex and relatively expensive. Summary of the Invention
[0006] To address the aforementioned technical problems, this invention proposes a method for preparing an antibacterial nanofiltration membrane using amikacin (AMK) as the aqueous monomer. Amikacin is an inexpensive and readily available antibiotic containing numerous hydrophilic groups such as hydroxyl and amino groups, exhibiting excellent antibacterial properties. The antibacterial nanofiltration membrane prepared by this invention combines high flux, high tetracycline rejection rate, low monovalent salt rejection rate, and antibacterial performance.
[0007] To achieve the above objectives, the present invention provides the following technical solution: This invention provides a method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer, comprising the following steps: AMK, sodium dodecyl sulfate (SDS), triethylamine (TEA), and water were mixed and stirred until homogeneous to obtain an aqueous solution of AMK. SDS, an anionic surfactant, was introduced to improve the wettability of the support layer. Enhanced wettability facilitates uniform impregnation of the base film with the aqueous amine monomer solution and promotes smooth transport of monomers from the base film to the reaction interface and the acyl chloride-containing organic phase. These effects improve the efficiency, controllability, and uniformity of the interfacial polymerization process. TEA, as an acid scavenger, neutralizes acidity and reduces acid-induced reaction inhibition, as hydrochloric acid is produced as a byproduct when amine monomers react with acyl chloride groups. It also shifts the equilibrium towards polyamide formation, thereby promoting more complete crosslinking. Trimethylbenzene chloride (TMC) was added to n-hexane and stirred until homogeneous to obtain an oil phase solution of TMC. The base membrane is fully immersed in the aqueous solution of AMK, then removed, the membrane surface is dried, and then immersed in the oil solution of TMC. The interfacial polymerization reaction forms a polyamide separation layer. The base membrane forming the polyamide separation layer is heat-treated to obtain the antibacterial nanofiltration membrane.
[0008] Further, in the aqueous solution of AMK, the mass fraction of AMK is 1.0-3.0%, the mass fraction of sodium dodecyl sulfate is 0.05%-0.1%, and the mass fraction of triethylamine is 0.5%-1.0%; preferably, in the aqueous solution of AMK, the mass fraction of AMK is 1.0-3.0%, the mass fraction of sodium dodecyl sulfate is 0.1%, the mass fraction of triethylamine is 1.0%, and the pH of the aqueous solution of AMK is 8.03.
[0009] Furthermore, in the oil phase solution of the TMC, the mass fraction of TMC is 0.1~0.3%.
[0010] Furthermore, the time for the interfacial polymerization reaction is 30~90 s.
[0011] Furthermore, the heat treatment temperature is 60 °C and the time is 2~5 min.
[0012] The present invention also provides a nanofiltration membrane with antibacterial properties prepared according to the above method, which is a polyamide nanofiltration composite membrane.
[0013] The antibacterial nanofiltration membrane provided by this invention can be used as an antibacterial material.
[0014] The present invention also provides an application of the above-mentioned antibacterial nanofiltration membrane in the field of membrane separation.
[0015] Furthermore, the antibacterial nanofiltration membrane is used to separate tetracycline and monovalent salts.
[0016] Compared with the prior art, the present invention has the following advantages and technical effects: 1. Amikacin monomers are relatively hydrophilic, and the slower diffusion rate of AMK leads to a reduced reaction rate, avoiding rapid exothermic reactions, thus reducing interfacial disturbances and promoting the formation of a smooth surface. The introduction of the hydrophilic macromolecule amikacin enhances the hydrophilicity of the membrane surface; the reduction in roughness and the enhanced hydrophilicity are beneficial to improving the membrane's antifouling performance. Since the added amikacin is an aminoglycoside antibiotic with potent bactericidal activity against Gram-negative bacteria and some Gram-positive bacteria, the prepared nanofiltration membrane exhibits good antifouling properties.
[0017] 2. The advantages of this invention are that the preparation method is simple to operate, the reaction conditions are mild, and the raw material cost is relatively low. In addition, the prepared antibacterial nanofiltration membrane (amikacin nanofiltration membrane) maintains high flux while also endowing the membrane material with excellent antibacterial properties, which can effectively inhibit the adhesion of microorganisms to the membrane surface and the formation of biofilm, and significantly improve the membrane's resistance to biofouling. Attached Figure Description
[0018] The accompanying drawings, which form part of this invention, are used to provide a further understanding of the invention. The illustrative embodiments of the invention and their descriptions are used to explain the invention and do not constitute an undue limitation of the invention. In the drawings: Figure 1 These are electron microscope images of the film obtained in Example 1 and Comparative Example 1. Figure 2 The diagram shows the antibacterial properties of the membranes obtained in Example 1 and Comparative Example 1 against the Gram-negative bacterium Escherichia coli (E. coli). Figure 3 The diagram shows the antibacterial properties of the membranes obtained in Example 1 and Comparative Example 1 against the Gram-positive bacterium Staphylococcus aureus. Detailed Implementation
[0019] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0020] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Every smaller range between any stated value or intermediate value within a stated range, and any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.
[0021] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.
[0022] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be apparent to those skilled in the art. This specification and embodiments are merely exemplary.
[0023] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.
[0024] An embodiment of the present invention provides a method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer, comprising the following steps: AMK (CAS:39831-55-5), SDS, TEA and water were mixed and stirred until homogeneous to obtain an aqueous solution of AMK. TMC was added to n-hexane and stirred until homogeneous to obtain an oil phase solution of TMC. The base membrane was fully immersed in the aqueous phase solution of AMK, then removed, and the membrane surface was dried before being immersed in the oil phase solution of TMC. The interfacial polymerization reaction formed a polyamide separation layer. The base membrane forming the polyamide separation layer is heat-treated to obtain an antibacterial nanofiltration membrane.
[0025] In a preferred embodiment of the present invention, in the aqueous solution of AMK, the mass fraction of AMK is 1.0-3.0%, the mass fraction of sodium dodecyl sulfate is 0.05%-0.1%, and the mass fraction of triethylamine is 0.5%-1.0%; preferably, in the aqueous solution of AMK, the mass fraction of AMK is 3.0%, the mass fraction of sodium dodecyl sulfate is 0.1%, the mass fraction of triethylamine is 1.0%, and the pH of the aqueous solution of AMK is 8.03.
[0026] In a preferred embodiment of the present invention, the mass fraction of TMC in the oil phase solution of TMC is 0.1~0.3%, preferably 0.2%.
[0027] In a preferred embodiment of the present invention, the immersion time of the base film in the aqueous solution of AMK is 60~120 s.
[0028] In a preferred embodiment of the present invention, the interfacial polymerization reaction time is 30-90 s, preferably 30-60 s, and more preferably 30 s.
[0029] In a preferred embodiment of the present invention, the heat treatment temperature is 60 °C and the time is 2 to 5 min, preferably 3 to 4 min.
[0030] Embodiments of the present invention also provide a nanofiltration membrane with antibacterial properties prepared according to the above method, which is a polyamide nanofiltration composite membrane that combines high flux, high tetracycline rejection rate, low monovalent salt rejection rate, and antibacterial properties.
[0031] The antibacterial nanofiltration membrane provided by this invention can be used as an antibacterial material.
[0032] Embodiments of the present invention also provide an application of the above-mentioned antibacterial nanofiltration membrane in the field of membrane separation.
[0033] In a preferred embodiment of the invention, an antibacterial nanofiltration membrane is used to separate tetracycline and monovalent salts.
[0034] For example, a monovalent salt is sodium chloride.
[0035] This invention utilizes amikacin as an aqueous monomer to prepare a polyamide nanofiltration membrane via interfacial polymerization: The base membrane is immersed in an aqueous solution containing amikacin, and then immersed in a hexane solution containing trimesoyl chloride for interfacial polymerization to form a polyamide separation layer. The membrane is then dried to obtain the polyamide nanofiltration membrane. The advantages of this invention are its simple preparation method, mild reaction conditions, and relatively low raw material cost. Furthermore, the prepared polyamide composite nanofiltration membrane exhibits higher selective permeation performance and good antibacterial properties. The flux of the prepared nanofiltration membrane can reach up to 20 L / (m²). 2(·h·bar), the tetracycline rejection rate can be as high as 99.3%. Furthermore, this invention can also provide a reference for the preparation of other antibacterial interfacial polymeric separation membranes.
[0036] Retention rate and water flux evaluation: Retention rate and water flux are two important parameters for evaluating the separation performance of nanofiltration membranes. The separation performance of nanofiltration membranes is evaluated through cross-flow permeation tests.
[0037] Retention rate is defined as the ability of a nanofiltration membrane to remove specific solutes (such as salt ions, organic matter, etc.) from the feed solution, expressed as a percentage. Specifically, it reflects the degree to which the concentration of the solute in the permeate decreases relative to the concentration in the feed solution—a higher retention rate indicates a better separation effect of the membrane for that substance.
[0038] Water flux is defined as the volume of water passing through a unit membrane area per unit time and unit pressure under certain operating conditions, and its unit is L / (m²). 2 ·h·bar).
[0039] The operating conditions used for the nanofiltration membrane performance determination in this invention are as follows: the influent is an aqueous solution of 20 mg / L tetracycline (TC) and 2 g / L sodium chloride (NaCl), the operating pressure is 0.5 MPa, the flow rate is 6 L / min, the operating temperature is 25 ℃, and the pH of the aqueous solution is 6.8.
[0040] Unless otherwise specified, the room temperature in this invention is 25±2 ℃.
[0041] All raw materials used in the embodiments of this invention were purchased commercially. Amikacin was purchased commercially, with CAS number 39831-55-5. In the following embodiments, the base membrane used was a polysulfone ultrafiltration membrane (molecular weight cutoff of 30~100kDa).
[0042] It should be noted that any aspects not described in detail in this invention are conventional practices in the field and are not the focus of this invention.
[0043] The technical solution of the present invention will be further illustrated by the following embodiments.
[0044] Example 1 A method for preparing an antibacterial nanofiltration membrane using amikacin (AMK) as an aqueous monomer, comprising the following steps: Preparation of AMK aqueous solution: Mix AMK, sodium dodecyl sulfate, triethylamine and water, stir well to obtain an AMK aqueous solution, denoted as AMK solution, wherein the mass fraction of AMK is 1.5%, the mass fraction of sodium dodecyl sulfate is 0.1%, the mass fraction of triethylamine is 1.0%, and the pH of the AMK aqueous solution is 8.03 (the same below). Preparation of an oil phase solution of trimesoyl chloride (TMC): TMC was added to n-hexane and stirred until homogeneous to obtain an oil phase solution of TMC, denoted as TMC solution, wherein the mass fraction of TMC was 0.2%. The AMK solution was contacted with the polysulfone ultrafiltration membrane for 2 min (the base membrane was completely immersed in the AMK solution), and then the membrane surface was dried with an air knife. Next, it was immersed in TMC solution and reacted for 30 s (i.e., the interfacial polymerization time was 30 s). After draining the TMC solution, the nanofiltration membrane was rinsed with n-hexane. Finally, it was heat-treated at 60 ℃ for 3 min to obtain an antibacterial nanofiltration membrane, which is a polyamide nanofiltration composite membrane, and stored in deionized water at room temperature.
[0045] Example 2 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 1, except that the mass fraction of AMK in the AMK solution is 2.0%.
[0046] Example 3 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 1, except that the mass fraction of AMK in the AMK solution is 2.5%.
[0047] Example 4 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 1, except that the mass fraction of AMK in the AMK solution is 3.0%.
[0048] Examples 1-4 were prepared by interfacial polymerization of AMK and TMC to prepare thin-layer composite membranes. Specifically, AMK was used as an aqueous monomer in Examples 1-4 with mass fractions of 1.5%, 2.0%, 2.5%, and 3.0%, respectively. Polyamide nanofiltration composite membranes were prepared by interfacial polymerization of AMK with an organic phase solution containing 0.2% TMC for 30 seconds. These four examples were used to investigate the effect of aqueous monomer concentration on membrane performance.
[0049] The aqueous phase concentrations of Examples 1 to 4 and the performance of the obtained antibacterial nanofiltration membranes are shown in Table 1.
[0050] Table 1 The results in Table 1 show that the polyamide nanofiltration composite membrane prepared with an aqueous monomer concentration of 3.0 wt% has better separation performance.
[0051] Example 5 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer, comprising the following steps: Preparation of an aqueous solution of AMK: AMK, sodium dodecyl sulfate, triethylamine and water were mixed and stirred until homogeneous to obtain an aqueous solution of AMK, denoted as AMK solution, wherein the mass fraction of AMK was 3.0%, the mass fraction of sodium dodecyl sulfate was 0.1%, and the mass fraction of triethylamine was 1.0%. Preparation of TMC oil phase solution: TMC is added to n-hexane and stirred until homogeneous to obtain an oil phase solution of TMC, denoted as TMC solution, wherein the mass fraction of TMC is 0.1%; The AMK solution was contacted with the base membrane (same as in Example 1) for 2 min, and then the membrane surface was dried with an air knife. Next, it was immersed in TMC solution and reacted for 30 s. After draining the TMC solution, the nanofiltration membrane was rinsed with n-hexane. Finally, it was heat-treated at 60 °C for 3 min to obtain an antibacterial nanofiltration membrane, which is a polyamide nanofiltration composite membrane, and stored in deionized water at room temperature.
[0052] Example 6 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 5, except that the mass fraction of TMC in the TMC solution is 0.3%.
[0053] Examples 4 to 6 investigated the effect of organic phase monomer concentration on membrane performance, and the results are shown in Table 2.
[0054] Table 2 The results in Table 2 show that when the concentration of the organic phase monomer used is 0.2 wt%, the prepared polyamide nanofiltration composite membrane has better separation performance.
[0055] Example 7 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer, comprising the following steps: Preparation of an aqueous solution of AMK: AMK, sodium dodecyl sulfate, triethylamine and water were mixed and stirred until homogeneous to obtain an aqueous solution of AMK, denoted as AMK solution, wherein the mass fraction of AMK was 3.0%, the mass fraction of sodium dodecyl sulfate was 0.1%, and the mass fraction of triethylamine was 1.0%. Preparation of TMC oil phase solution: TMC is added to n-hexane and stirred until homogeneous to obtain an oil phase solution of TMC, denoted as TMC solution, wherein the mass fraction of TMC is 0.2%; The AMK solution was contacted with the base membrane (same as in Example 1) for 2 min, and then the membrane surface was dried with an air knife. Next, it was immersed in TMC solution and reacted for 60 s. After draining the TMC solution, the nanofiltration membrane was rinsed with n-hexane. Finally, it was heat-treated at 60 °C for 3 min to obtain an antibacterial nanofiltration membrane, which is a polyamide nanofiltration composite membrane, and stored in deionized water at room temperature.
[0056] Example 8 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 7, except that the interfacial polymerization time is 90 s.
[0057] Examples 4, 7 and 8 investigated the effect of interfacial polymerization time on membrane performance, as shown in Table 3.
[0058] Table 3 The results in Table 3 show that the polyamide nanofiltration composite membrane prepared has better separation performance when the interfacial polymerization time is 30 s.
[0059] Example 9 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 4, except that the heat treatment time at 60 °C is 2 min.
[0060] Example 10 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 4, except that the heat treatment time at 60 °C is 4 min.
[0061] Example 11 A method for preparing an antibacterial nanofiltration membrane using AMK as an aqueous monomer is the same as in Example 4, except that the heat treatment time at 60 °C is 5 min.
[0062] Examples 4, 9 to 11 investigated the effect of heating time (i.e. heat treatment time) on membrane performance, as shown in Table 4.
[0063] Table 4 The results in Table 4 show that the polyamide nanofiltration composite membrane prepared has better separation performance when the heating time is 3 min and 4 min.
[0064] In Tables 1 to 4, when testing the retention rate (TC) and retention rate (NaCl), the test objects were 20 mg / L TC aqueous solution and 2 g / L NaCl aqueous solution, the test pressure was 0.5 MPa, and the test temperature was 25 ℃.
[0065] Comparative Example 1 Same as Example 1, except that the aqueous solution is a 3.0% (w / w) aqueous solution of piperazine (PIP), and the resulting membrane is referred to as PA-PIP membrane.
[0066] The flux, tetracycline rejection rate, and sodium chloride rejection rate of the piperazine-added polyamide composite nanofiltration membrane were tested at 0.5 MPa and 25 ℃ using 20 mg / L TC aqueous solution and 2 g / L NaCl aqueous solution, respectively, and were found to be 5.1 L / (m²). 2 (·h·bar), 99.8% and 33.8%.
[0067] Performance testing The films prepared in each embodiment and comparative example were characterized, and the results are analyzed as follows: Figure 1 The images show surface electron microscope (SEM) images of the membranes obtained in Example 1 and Comparative Example 1. The SEM images of Example 1 and Comparative Example 1 show that both membranes formed a uniform and continuous PA layer on the surface of the ultrafiltration membrane substrate. The PA-PIP membrane (i.e., the membrane obtained in Comparative Example 1) exhibits a typical nodular structure, while the PA-AMK membrane (i.e., the membrane obtained in Example 1) has a smoother surface. It is speculated that this difference in surface roughness is caused by the difference in monomer diffusion rates during interfacial polymerization. The PA-PIP membrane has a more pronounced ridge / fold morphology; increased surface roughness hinders the rapid passage of water molecules, prolonging their residence time on the membrane surface and thus reducing permeate flux. The slower diffusion rate of AMK leads to a reduced reaction rate, avoiding rapid exothermic reactions, thereby reducing interfacial disturbances and promoting the formation of a smooth surface. The rough surface of the PA-PIP membrane hinders the rapid passage of water molecules, increasing their residence time on the membrane surface, which in turn reduces flux. This result demonstrates that the scheme of using AMK as an aqueous solution in this invention is feasible, and the composite membrane prepared by the method of this invention has significant advantages in preparing a continuous selective layer.
[0068] Gram-negative Escherichia coli (E. coli) and Gram-positive Staphylococcus aureus (S. aureus) were selected as experimental bacterial strains to test the antibacterial properties of the membranes obtained in Example 1 and Comparative Example 1. The specific testing procedure was as follows: Activated bacterial solution was inoculated into liquid broth medium at a 1 wt% inoculum. Sterilized sample was added to the above system, and the mixture was incubated overnight at 37 ℃ and 180 rpm. The next day, after shaking the medium, an appropriate amount of bacterial solution was serially diluted and plated. Solid agar culture after serial dilution was incubated overnight at 37 ℃. After clearly visible single colonies grew, the plates were removed and counted. The colony count of each plate was counted, and the inhibition rate was calculated by comparing with the blank control. Figure 2 and Figure 3 The figures show the antibacterial properties of the membranes obtained in Example 1 and Comparative Example 1 against Gram-negative Escherichia coli (E. coli) and Gram-positive Staphylococcus aureus (S. aureus), respectively. Figure 2 and Figure 3As shown, the PA-PIP membrane did not exhibit a significant antibacterial effect under contact culture conditions, indicating that its surface mainly acts as an inert carrier interface, allowing bacteria to complete the conventional process of initial adsorption—irreversible adhesion—proliferation / biofilm precursor formation. In contrast, the PA-AMK membrane showed significant growth inhibition against both E. coli and S. aureus, indicating that AMK was effectively introduced into the outermost polyamide skin layer of the membrane and imparted interfacial antibacterial activity. After AMK accumulated in the membrane / bacterial contact layer, it interacted with the cell surface through local high concentrations at the interface, achieving immediate inhibition of attached cells and further leading to cell inactivation. On the other hand, the limited dissolution of surface / shallow AMK could establish a near-surface concentration gradient around the membrane, generating an observable inhibition zone, thus demonstrating the combined effect of contact action and local diffusion. In addition, the introduction of AMK may also be accompanied by enhanced surface hydrophilicity and electrophoresis, forming a more stable hydration layer and weakening irreversible bacterial adhesion, thus reducing cell colonization and subsequent growth together with contact inhibition.
[0069] The above are merely preferred embodiments of the present invention, but the scope of protection of the present invention is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in the present invention should be included within the scope of protection of the present invention.
Claims
1. A method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer, characterized in that, Includes the following steps: Amikacin, sodium dodecyl sulfate, triethylamine and water were mixed and stirred until homogeneous to obtain an aqueous solution of amikacin. Add pyromellitic chloride to n-hexane and stir until homogeneous to obtain an oil phase solution of pyromellitic chloride; The base membrane is fully immersed in the aqueous solution of amikacin, then removed, and the membrane surface is dried before being immersed in the oil solution of trimesoyl chloride. The interfacial polymerization reaction forms a polyamide separation layer. The base membrane forming the polyamide separation layer is heat-treated to obtain the antibacterial nanofiltration membrane.
2. The method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer according to claim 1, characterized in that, In the aqueous solution of amikacin, the mass fraction of amikacin is 1.0% to 3.0%, the mass fraction of sodium dodecyl sulfate is 0.05% to 0.1%, and the mass fraction of triethylamine is 0.5% to 1.0%.
3. The method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer according to claim 2, characterized in that, In the aqueous solution of amikacin, the mass fraction of amikacin is 1.0-3.0%, the mass fraction of sodium dodecyl sulfate is 0.1%, and the mass fraction of triethylamine is 1.0%.
4. The method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer according to claim 1, characterized in that, In the oil phase solution of the pyromellitic chloride, the mass fraction of the pyromellitic chloride is 0.1~0.3%.
5. The method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer according to claim 1, characterized in that, The time for the interfacial polymerization reaction is 30~90 s.
6. The method for preparing an antibacterial nanofiltration membrane using amikacin as an aqueous monomer according to claim 1, characterized in that, The heat treatment is performed at a temperature of 60 °C for 2 to 5 minutes.
7. A nanofiltration membrane with antibacterial properties, characterized in that, It is prepared according to any one of claims 1 to 6.
8. The application of an antibacterial nanofiltration membrane as described in claim 7 in the field of membrane separation.
9. The application according to claim 8, characterized in that, The antibacterial nanofiltration membrane is used to separate tetracycline and monovalent salts.
